Moderated Poster

Poster, Podium & Video Sessions

MP29-15: Biopsychosocial Predictors of Suicidality in Patients with Interstitial Cystitis/Bladder Pain Syndrome

Saturday, May 13
9:30 AM - 11:30 AM
Location: BCEC: Room 151

Presentation Authors: Dean Tripp*, J Curtis Nickel, Joel Dueck, Abigale Muere, Haley Yurgan, Madelaine Gierc, Kingston, Canada

Introduction: Suicide is a significant problem in the general and chronic pain population. Although two studies have examined the prevalence and predictors of suicidal ideation in people suffering from Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS), these studies are limited by their sample selection, assessment of suicidal thinking and behaviour or risk, and the lack of any direct assessment of variables in current theories of suicide.

The current study examines the prevalence of suicide risk and the significance of various demographic and biopsychosocial factors that are theoretically implicated in the prediction of suicide risk in an IC/BPS sample.

Methods: Female patients currently suffering from IC/BPS (N=813) were recruited from online support groups and complete an online questionnaire containing measures of demographic, pain, symptoms, and psychosocial variables.

Results: The sample was split into groups of suicide risk, based on an adult general population cut-off score of ≥7 for the SBQ-R, creating a not at risk group (n = 503, M = 3.96, SD = 1.11) and an at risk group (n = 310, M = 9.73, SD = 2.65). This data split showed that 310 participants, or 38.1% of the sample, were at risk for suicide. Alternatively, using the more conservative cut-off score of ≥8 (based on an adult inpatient population), 233 participants, or 28.7%, were at risk for suicide (see Figure 1). In regression analyses testing empirically/theoretically implicated contributors to suicidal behaviour, exposure to suicide, pain catastrophizing, psychache, hopelessness and perceived burdensomeness were found to significantly predict suicide risk. Further, regressions for low, moderate and severe pain patients groups showed that hopelessness was the strongest predictor of suicide risk in low pain patient group; psychache in the moderate pain group: and perceived burdensomeness in severe pain group.

Conclusions: The high prevalence of suicidality presented in this study denotes the imperative of recognizing suicidality within the IC/BPS population. Further, the identified psychosocial risk factors will be useful in improving screening and to anchor potential treatment targets for suicidality in IC/BPS.

Source Of Funding: NONE

Dean A. Tripp, PhD

Queen's University

Dr Tripp completed his Clinical Psychology PhD at Dalhousie University (Canada). He has held positions at several universities before joining Queen’s in 2001. Dr Tripp is currently an Associate Professor in the Departments of Psychology, Anesthesiology and Urology.

Dr Tripp has been acclaimed for his teaching and research and has been awarded the 2011 “Excellence in Interprofessional Pain Education Award” from the Canadian Pain Society. Dr Tripp has been short-listed and received several “Teaching Excellence” Awards.

His current lines of research concern chronic pain and psychosocial factors associated with adjustment within patient populations. New grants and research projects are focused on pain, relationship distress, and disability in men suffering from Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) and women suffering from chronic Interstitial Cystitis (IC) as well as Inflamatory Bowel Disease (IBD) and Arthritis. His work with his NIH NIDDK colleagues in Pelvic Pain has garnered international attention.

Dr Tripp has published over 60 peer-reviewed publications, & chapters, two treatment manuals, and has presented his research in both national and international forums.


Send Email for Dean Tripp


MP29-15: Biopsychosocial Predictors of Suicidality in Patients with Interstitial Cystitis/Bladder Pain Syndrome

Attendees who have favorited this

Send Email for Biopsychosocial Predictors of Suicidality in Patients with Interstitial Cystitis/Bladder Pain Syndrome